Related references
Note: Only part of the references are listed.Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial
A. Taieb et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Rosacea Part I. Introduction, categorization, histology, pathogenesis, and risk factors
Aimee M. Two et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
The psychological impact of rosacea and the influence of current management options
Farah Moustafa et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Emerging therapies in rosacea
Alison Layton et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin
Kimberly N. Kanada et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Clinical, Cellular, and Molecular Aspects in the Pathophysiology of Rosacea
Martin Steinhoff et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2011)
Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway
Xinxin Ci et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
Comorbidity of rosacea and depression: An analysis of the national ambulatory medical care survey and National Hospital Ambulatory Care Survey - outpatient department data collected by the US National Center for Health Statistics from 1995 to 2002
MA Gupta et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea
J Wilkin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Share Paper
